RESUMO
Src homology 3 (SH3) domains are found in a variety of proteins that are involved in signal transduction or represent components of the cytoskeleton. These domains are thought to serve as modules that mediate specific protein-protein interactions that include proline-rich sequences on the target protein. We have identified proteins of 110, 80, 65, and 43 kDa in human embryonic fibroblasts that bind specifically to the SH3 domain of phospholipase C gamma, a primary substrate of receptor tyrosine kinases, and characterized the 110-kDa band as the microtubule-activated GTPase dynamin. In addition, dynamin binds the son of sevenless adaptor protein GRB-2 with even higher affinity. This interaction does not require the dynamin GTPase function and involves a proline-rich target sequence between residues 812 and 820 of dynamin.
Assuntos
Proteínas Adaptadoras de Transdução de Sinal , GTP Fosfo-Hidrolases/metabolismo , Microtúbulos/enzimologia , Proteínas/metabolismo , Fosfolipases Tipo C/metabolismo , Sequência de Aminoácidos , Dinaminas , Proteína Adaptadora GRB2 , Genes src , Glutationa Transferase/genética , Humanos , Dados de Sequência Molecular , Ligação Proteica , Conformação Proteica , Proteínas Recombinantes de Fusão , Transdução de SinaisRESUMO
Despite the ubiquitous presence of basic fibroblast growth factor (bFGF) in normal tissues, endothelial cell proliferation in these tissues is usually very low, suggesting that bFGF is somehow sequestered from its site of action. Immunohistochemical staining revealed the localization of bFGF in basement membranes of diverse tissues, suggesting that the extracellular matrix (ECM) may serve as a reservoir for bFGF. Moreover, functional studies indicated that bFGF is an ECM component required for supporting endothelial cell proliferation and neuronal differentiation. We have found that bFGF is bound to heparan sulfate (HS) in the ECM and is released in an active form when the ECM-HS is degraded by heparanase expressed by normal and malignant cells (i.e. platelets, neutrophils, lymphoma cells). It is proposed that restriction of bFGF bioavailability by binding to ECM and local regulation of its release provide a novel mechanism for neovascularization in normal and pathological situations. The subendothelial ECM contains also tissue type- and urokinase type-plasminogen activators which participate in cell invasion and tissue remodeling. These results and studies on the properties of other ECM-immobilized enzymes (i.e. thrombin, plasmin, lipoprotein lipase) and growth factors (GM-CSF, IL-3, osteogenin), suggest that the ECM provides a storage depot for biologically active molecules which are thereby stabilized and protected. This may allow a more localized and persistent mode of action, as compared to the same molecules in a fluid phase.
Assuntos
Proteínas da Matriz Extracelular/fisiologia , Fator 2 de Crescimento de Fibroblastos/fisiologia , Glucuronidase , Neovascularização Patológica , Animais , Membrana Basal/química , Plaquetas/metabolismo , Bovinos , Diferenciação Celular , Divisão Celular , Córnea , Endotélio Vascular/química , Endotélio Vascular/citologia , Matriz Extracelular/química , Glicosídeo Hidrolases/metabolismo , Substâncias de Crescimento/isolamento & purificação , Humanos , Linfoma/patologia , Células-Tronco Neoplásicas/metabolismo , Neurônios/citologia , Neutrófilos/metabolismo , Especificidade de ÓrgãosAssuntos
Fator 2 de Crescimento de Fibroblastos/metabolismo , Glucuronidase , Animais , Membrana Basal/metabolismo , Plaquetas/enzimologia , Compartimento Celular , Diferenciação Celular , Divisão Celular , Endotélio/citologia , Endotélio/efeitos da radiação , Matriz Extracelular/metabolismo , Glicosídeo Hidrolases/metabolismo , Heparitina Sulfato/metabolismo , Humanos , Metástase Neoplásica , Neoplasias/enzimologia , Neurônios/citologia , Neutrófilos/enzimologia , Fosfatidilinositol Diacilglicerol-Liase , Diester Fosfórico Hidrolases/metabolismoRESUMO
Neoplastic cells require an appropriate pericellular environment and new formation of stroma and blood vessels in order to constitute a solid tumor. Tumor progression also involves degradation of various extracellular matrix (ECM) constituents. In this review we have focused on the possible involvement of ECM-resident growth factors and enzymes in neovascularization and cell invasion. We demonstrate that the pluripotent angiogenic factor, basic fibroblast growth factor (bFGF) is an ECM component required for supporting cell proliferation and differentiation. Basic FGF has been identified in the subendothelial ECM produced in vitro and in basement membranes of the cornea and blood vessels in vivo. Despite the ubiquitous presence of bFGF in normal tissues, endothelial cell (EC) proliferation in these tissues is usually very low, suggesting that bFGF is somehow sequestered from its site of action. Our results indicate that bFGF is bound to heparan sulfate (HS) in the ECM and is released in an active form when the ECM-HS is degraded by cellular heparanase. We propose that restriction of bFGF bioavailability by binding to ECM and local regulation of its release, provides a novel mechanism for regulation of capillary blood vessel growth in normal and pathological situations. Heparanase activity correlates with the metastatic potential of various tumor cells and heparanase inhibiting molecules markedly reduce the incidence of lung metastasis in experimental animals. Heparanase may therefore participate in both tumor cell invasion and angiogenesis through degradation of the ECM-HS and mobilization of ECM-resident EC growth factors. The subendothelial ECM contains also tissue type- and urokinase type- plasminogen activators (PA), as well as PA inhibitor which may regulate cell invasion and tissue remodeling. Heparanase and the ECM-resident PA participate synergistically in sequential degradation of HS-proteoglycans in the ECM. These results together with similar observations on the properties of other ECM-immobilized enzymes and growth factors, suggest that the ECM provides a storage depot for biologically active molecules which are thereby stabilized and protected. This may allow a more localized, regulated and persistent mode of action, as compared to the same molecules in a fluid phase.
Assuntos
Matriz Extracelular/química , Glucuronidase , Metástase Neoplásica/fisiopatologia , Neovascularização Patológica/fisiopatologia , Animais , Matriz Extracelular/enzimologia , Fator 2 de Crescimento de Fibroblastos/fisiologia , Glicosídeo Hidrolases/fisiologia , Heparitina Sulfato/fisiologia , Humanos , Ativadores de Plasminogênio/fisiologia , Inativadores de Plasminogênio/metabolismoRESUMO
Mast cells are widely distributed in perivascular connective tissues, especially in areas of active tumor growth and vascular reactivity. Incubation of metabolically [35S]O4 = -labeled subendothelial extracellular matrix (ECM) with lysates of bone marrow-derived mouse mast cells (BMMC) resulted in extensive degradation of heparan sulfate (HS) into fragments 5 to 6 times smaller than intact HS side chains. A much lower activity (seven- to eightfold) was expressed by intact BMMC incubated in contact with the ECM. These fragments were not produced in the presence of heparin, were sensitive to deamination with nitrous acid, and resistant to further degradation with papain or chondroitinase ABC. These results indicate that an endoglycosidase (heparanase) is involved in BMMC-mediated degradation of HS in the subendothelial ECM. Heparanase activity was not detected in medium conditioned by cultured BMMC, or in lysates of Ableson transformed BMMC and rat basophilic leukemic (RBL) cells. Both heparanase and beta-hexosaminidase, a mast cell granule enzyme, were released on degranulation of BMMC induced by the calcium ionophore A23187, or by exposure to IgE-Ag, suggesting that heparanase is localized in the cell granules. Under these conditions, less than 5% of the cellular content of lactate dehydrogenase were released. Degradation of the ECM-HS by the mast cell heparanase and the associated release of HS-bound endothelial cell growth factors that are stored in ECM (Vlodavsky et al, Proc Natl Acad Sci USA 84:2292, 1987; Bashkin et al, Biochemistry 28:1737, 1989) may play a role in the proposed mast cell-mediated stimulation of neovascularization.
Assuntos
Endotélio Vascular/citologia , Matriz Extracelular/metabolismo , Glucuronidase , Glicosaminoglicanos/metabolismo , Glicosídeo Hidrolases/metabolismo , Heparitina Sulfato/metabolismo , Mastócitos/fisiologia , Animais , Células da Medula Óssea , Degranulação Celular/fisiologia , Endotélio Vascular/efeitos dos fármacos , Matriz Extracelular/análise , Matriz Extracelular/efeitos dos fármacos , Glicosídeo Hidrolases/farmacologia , Glicosídeo Hidrolases/fisiologia , Heparitina Sulfato/análise , Masculino , Mastócitos/enzimologia , Mastócitos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Neovascularização Patológica/fisiopatologia , Proteoglicanas/metabolismoRESUMO
We have examined morphological events in RBL-2H3 basophilic leukocyte-derived cells following stimulation to secrete with specific antigen. Following stimulation, the cell surface undergoes a rapid and pronounced ruffling concomitant with an overall flattening. Secretory granules which are located in one area before stimulation becomes rapidly dispersed throughout the cytoplasm. Since secretion has been shown to be a relatively slow process in the RBL-2H3 cell line our observations suggest that ruffling and flattening precede the secretion process.
Assuntos
Leucemia Experimental/patologia , Animais , Antígenos/imunologia , Basófilos/ultraestrutura , Células Cultivadas , Meios de Cultura , Grânulos Citoplasmáticos/ultraestrutura , Leucemia Experimental/imunologia , Microscopia Eletrônica de Varredura , RatosRESUMO
Recently, variants of the rat basophilic leukemia cells (RBL-2H3), deficient in their binding capacity for the antiallergic drug cromolyn but displaying unimpaired ability to bind IgE, were selected and cloned [Mazurek, N., Bashkin, P., Petrank, A. & Pecht, I. (1983) Nature (London) 303, 528-530]. Although the histamine content and the number of IgE receptors in these variants are similar to those of the parental cells, they cannot be stimulated immunologically to allow Ca(2+) influx and to degranulate. In contrast, the Ca(2+) ionophore A23187 causes these variants to degranulate, indicating that the mechanism distal to the Ca(2+) gating is intact in the variants. The cromolyn binding protein (CBP), present in the membranes of RBL-2H3 cells, has recently been isolated by affinity chromatography under nondenaturing conditions. In the current study we have used Sendaivirus envelopes as fusogenic carriers to implant the purified CBP into the membrane of variant basophils that were defective in it. This fusion leads to the restoration of Ca(2+) uptake and degranulation capacity of the variants after IgE-mediated stimulation. These restored activities seem to show a sigmoidal dependence on the amount of incorporated CBP. Saturation values comparable to those of the parental line are reached when the level of implanted CBP approaches its density on the latter line. The restored capacity is due to the implanted CBP, because the reinstated immunological response can be blocked by the inhibitory drug cromolyn and by monoclonal antibodies specific to CBP, both shown to prevent Ca(2+) uptake and degranulation in mast cells and parental RBL-2H3 cells. These results point out that CBP plays an important role in the Ca(2+) gating process resulting in degranulation.
Assuntos
Cálcio/metabolismo , Proteínas de Transporte/imunologia , Leucemia Experimental/imunologia , Animais , Basófilos/imunologia , Basófilos/metabolismo , Transporte Biológico Ativo , Fusão Celular , Linhagem Celular , Variação Genética , Leucemia Experimental/metabolismo , Proteínas de Membrana , Ratos , Ratos EndogâmicosRESUMO
Cromoglycate, which inhibits IgE-mediated degranulation of mast cells and a basophilic rat tumour cell line (RBL-2H3) (ref.3), is a drug widely used in the treatment of allergic asthma. We have demonstrated the presence of specific binding sites for that drug on the membranes of basophils and mast cells and more recently, we have succeeded in isolating the cromoglycate-binding protein from the membranes of RBL-2H3 cells. These findings together with the chelation by cromoglycate of alkaline-earth ions in low polarity medium, suggest that the binding site of the drug may either be part, or closely related to the calcium gate. To further investigate this, we have selected variants of the RBL-2H3 cell line that are defective in cromoglycate binding but bind IgE normally. In these variants, which have similar histamine content to the parental cells, IgE-mediated challenge did not lead to Ca2+ influx, degranulation and histamine release. In contrast, these cells were able to release histamine on exposure to the Ca2+ ionophore A23187, indicating that the degranulation mechanism distal to the Ca2+ gating step is unaffected. Taken together, these findings suggest that cromoglycate-binding protein has a role in the transmembrane calcium influx which induces degranulation.
Assuntos
Basófilos/imunologia , Cromolina Sódica/metabolismo , Animais , Basófilos/fisiologia , Linhagem Celular , Imunofluorescência , Imunoglobulina E/imunologia , Imunoglobulina E/metabolismo , Ligação Proteica , RatosRESUMO
The membrane protein component in basophils, responsible for the specific, Ca2+-dependent, binding of the anti-allergic drug cromolyn [disodium cromoglycate, DSCG; the disodium salt of 1,2 bis(2- carboxychromon -5- yloxy )-2-hydroxy propane] was isolated by two procedures based on affinity for the drug. In the first procedure, involving immunoprecipitation, rat basophilic leukemia cells (RBL-2H3), surface labeled by 125I were reacted with a polyvalent conjugate of DSCG and bovine serum albumin and then subjected to solubilization by the non-ionic detergent Nonidet P-40 (NP-40). From these lysates, precipitation was specifically attained by subsequent addition of rabbit anti-DSCG antibodies. In an SDS-polyacrylamide gel electrophoresis (SDS-PAGE), a single radioactive band was observed, having an apparent mol. wt. of 60 000 daltons. Competitive inhibition of the immunoprecipitation in the presence of free drug or excess of EDTA demonstrated the specificity of the isolation. Furthermore, this particular membrane component could not be isolated from several other cell types examined. The second isolation from several other cell types examined. The second isolation procedure employed affinity chromatography on DSCG immobilized on polyacryl- hydrazido agarose beads. The DSCG-binding protein was eluted from the affinity column with either DSCG or with EDTA and also migrated on SDS-PAGE as a single band of 60 000 mol. wt., similar to that obtained by the immunoprecipitation procedure. These and other results suggest that this newly isolated protein is the one responsible for the Ca2+-dependent binding of the drug to the basophil membrane.